Mercer Global Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$949K Sell
11,444
-5,047
-31% -$419K ﹤0.01% 1221
2025
Q1
$1.34M Buy
16,491
+3,751
+29% +$304K ﹤0.01% 990
2024
Q4
$1.15M Buy
12,740
+1,651
+15% +$149K ﹤0.01% 1042
2024
Q3
$1.09M Sell
11,089
-39
-0.4% -$3.83K ﹤0.01% 987
2024
Q2
$1.03M Buy
11,128
+3,214
+41% +$298K ﹤0.01% 954
2024
Q1
$749K Buy
7,914
+1,169
+17% +$111K ﹤0.01% 1083
2023
Q4
$602K Sell
6,745
-120
-2% -$10.7K ﹤0.01% 1214
2023
Q3
$501K Sell
6,865
-1,575
-19% -$115K ﹤0.01% 1251
2023
Q2
$702K Buy
8,440
+435
+5% +$36.2K ﹤0.01% 1082
2023
Q1
$610K Sell
8,005
-1,732
-18% -$132K ﹤0.01% 1105
2022
Q4
$808K Buy
9,737
+2,622
+37% +$218K ﹤0.01% 1003
2022
Q3
$564K Buy
7,115
+1,038
+17% +$82.3K ﹤0.01% 1078
2022
Q2
$451K Sell
6,077
-3,934
-39% -$292K ﹤0.01% 1198
2022
Q1
$900K Buy
10,011
+1,113
+13% +$100K 0.01% 940
2021
Q4
$996K Buy
8,898
+60
+0.7% +$6.72K 0.01% 885
2021
Q3
$1.11M Sell
8,838
-1
-0% -$126 0.01% 812
2021
Q2
$1.2M Buy
8,839
+665
+8% +$90.1K 0.01% 758
2021
Q1
$1.11M Buy
8,174
+3,850
+89% +$523K 0.01% 748
2020
Q4
$609K Sell
4,324
-696
-14% -$98K 0.01% 792
2020
Q3
$559K Buy
5,020
+1,125
+29% +$125K 0.01% 753
2020
Q2
$436K Buy
3,895
+357
+10% +$40K 0.01% 729
2020
Q1
$274K Sell
3,538
-117
-3% -$9.06K 0.01% 839
2019
Q4
$348K Sell
3,655
-1,550
-30% -$148K 0.01% 864
2019
Q3
$396K Buy
5,205
+165
+3% +$12.6K 0.01% 783
2019
Q2
$442K Buy
5,040
+1,024
+25% +$89.8K 0.01% 729
2019
Q1
$364K Buy
+4,016
New +$364K 0.01% 756